84年鼠女哪年财运最旺,857comvvv色九欧美激情|85PO_87国产精品欲av国产av资源

[1]劉福存,單樂天,童培建,等.附子湯治療輕中度膝骨關節(jié)炎寒濕痹阻證的臨床研究[J].中醫(yī)正骨,2016,28(01):10-13.
 LIU Fucun,SHAN Letian,TONG Peijian,et al.Clinical study on Fuzi Tang(附子湯)for treatment of mild-to-moderate knee osteoarthritis with COLD-DAMPNESS STAGNATION(寒濕痹阻)syndrome[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(01):10-13.
點擊復制

附子湯治療輕中度膝骨關節(jié)炎寒濕痹阻證的臨床研究()
分享到:

《中醫(yī)正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第28卷
期數(shù):
2016年01期
頁碼:
10-13
欄目:
臨床研究
出版日期:
2016-01-20

文章信息/Info

Title:
Clinical study on Fuzi Tang(附子湯)for treatment of mild-to-moderate knee osteoarthritis with COLD-DAMPNESS STAGNATION(寒濕痹阻)syndrome
作者:
劉福存1單樂天2童培建1鄒建琴1肖魯偉2
1.浙江省中醫(yī)院,浙江 杭州 310006;
2.浙江中醫(yī)藥大學骨傷研究所,浙江 杭州 310053
Author(s):
LIU Fucun1SHAN Letian2TONG Peijian1ZOU Jianqin1XIAO Luwei2
1.Zhejiang Provincial Hospital of Traditional Chinese Medicine,Hangzhou 310006,Zhejiang,China 2.Institute of Traumatology and Orthopedics Affiliated to Zhejiang University of Traditional Chinese Medicine,Hangzhou 310053,Zhejiang,China
關鍵詞:
骨關節(jié)炎 附子湯 氨基葡萄糖 痹證 臨床試驗
Keywords:
osteoarthritisknee Fuzi Tang chitosamine arthralgia syndrome clinical trial
摘要:
目的:觀察附子湯治療輕中度膝骨關節(jié)炎(knee osteoarthritis,KOA)寒濕痹阻證的臨床療效和安全性。方法:納入163例輕中度KOA寒濕痹阻證患者。82例服用附子湯(附子湯組),每日1劑,分2次服用,連服4周; 81例服用鹽酸氨基葡萄糖膠囊(氨基葡萄糖組),每日2次,每次0.75 g,連服4周。2組均以美洛昔康片作為應急用藥。分別于治療前及治療后5個月評定患者的西安大略和麥克馬斯特大學(Western Ontario and McMaster Universities,WOMAC)骨關節(jié)炎指數(shù)和50 m行走后膝關節(jié)疼痛視覺模擬量表(visual analogue scale,VAS)評分,并觀察患者的不良反應發(fā)生率和應急用藥率。結果:附子湯組1例患者服藥3 d后因口部感覺麻木停藥; 2組患者的不良反應發(fā)生率比較,差異無統(tǒng)計學意義(P=0.053)。治療后5個月時,附子湯組5例失訪、氨基葡萄糖組7例失訪; 因疼痛加重,附子湯組7例服用美洛昔康片、氨基葡萄糖組23例服用美洛昔康片,2組均無連續(xù)應用美洛昔康片超過3 d者,氨基葡萄糖組的應急用藥率高于附子湯組(χ2=10.701,P=0.001)。治療前2組患者50 m行走后膝關節(jié)疼痛VAS評分和WOMAC骨關節(jié)炎指數(shù)比較,組間差異均無統(tǒng)計學意義[(5.6±2.9)分,(5.8±3.1)分,t=0.425,P=0.671;(89.1±24.6),(88.4±26.3),t=0.176,P=0.861]; 治療后5個月,附子湯組50 m行走后膝關節(jié)疼痛VAS評分和WOMAC骨關節(jié)炎指數(shù)均小于氨基葡萄糖組[(2.1±3.8)分,(5.7±3.3)分,t=6.188,P=0.000;(29.7±19.8),(87.9±27.3),t=1.933,P=0.000]。結論:服用附子湯可有效減輕輕中度KOA寒濕痹阻證患者的膝關節(jié)疼痛癥狀,提高患者的生活質量,療效優(yōu)于氨基葡萄糖,而且不良反應較少。
Abstract:
Objective:To observe the clinical curative effects and safety of Fuzi Tang(附子湯)in treatment of mild-to-moderate knee osteoarthritis(KOA)with COLD-DAMPNESS STAGNATION(寒濕痹阻)syndrome.Methods:One hundred and sixty-three patients with mild-to-moderate KOA with COLD-DAMPNESS STAGNATION syndrome were enrolled in the study.Eighty-two patients were treated with oral application of Fuzi Tang(Fuzi Tang group),one dose at a time,twice a day for 4 consecutive weeks; while the others were treated with oral application of glucosamine hydrochloride capsules(glucosamine group),0.75g at a time,twice a day for 4 consecutive weeks.Meloxicam tablets were used to meet the emergency in the 2 groups.The Western Ontario and McMaster Universities(WOMAC)osteoarthritis index and knee pain visual analogue scale(VAS)scores after 50-m walk were evaluated and compared between the 2 groups before the treatment and at 5 months after the treatment respectively,and the incidence rate of adverse reactions and the rate of emergency medication were also observed.Results:Drug withdrawal were found in 1 patient for oral anesthesia after 3-day medication in Fuzi Tang group.There was no statistical difference in the incidence rate of adverse reactions between the 2 groups(P=0.053).Five patients in Fuzi Tang group and 7 patients in glucosamine group lost to follow-up at 5 months after the treatment.Seven patients in Fuzi Tang group and 23 patients in glucosamine group were given meloxicam tablets for aggravated knee pain for no more than 3 consecutive days,and the rate of emergency medication was higher in glucosamine group compared to Fuzi Tang group(χ2=10.701,P=0.001).There was no statistical difference between the 2 groups before the treatment in the knee pain VAS scores after 50-m walk and WOMAC osteoarthritis index(5.6+/-2.9 vs 5.8+/-3.1 points,t=0.425,P=0.671; 89.1+/-24.6 vs 88.4+/-26.3,t=0.176,P=0.861),which were less in Fuzi Tang group compared to glucosamine group at 5 months after the treatment(2.1+/-3.8 vs 5.7+/-3.3 points,t=6.188,P=0.000; 29.7+/-19.8 vs 87.9+/-27.3,t=1.933,P=0.000).Conclusion:Oral application of Fuzi Tang can effectively alleviate the knee pain and improve the quality of live of patients with mild-to-moderate KOA with COLD-DAMPNESS STAGNATION syndrome,moreover,it surpasses the glucosamine in the curative effects with less adverse reactions.

參考文獻/References:

[1] Tong P,Wu C,Wang X,et al.Development and assessment of a complete-detoxication strategy for Fuzi(lateral root of Aconitum carmichaeli)and its application in rheumatoid arthritis therapy[J].J Ethnopharmacol,2013,146(2):562-571.
[2] Tong P,Xu S,Cao G,et al.Chondroprotective activity of a detoxicated traditional Chinese medicine(Fuzi)of Aconitum carmichaeli Debx against severe-stage osteoarthritis model induced by mono-iodoacetate[J].J Ethnopharmacol,2014,151(1):740-744.
[3] Altman R,Asch E,Bloch D,et al.Development of criteria for the classification and reporting of osteoarthritis.Classification of osteoarthritis of the knee.Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association[J].Arthritis Rheum,1986,29(8):1039-1049.
[4] 中國中醫(yī)藥研究促進會骨科專業(yè)委員會,中國中西醫(yī)結合學會骨傷科專業(yè)委員會關節(jié)工作委員會.膝骨關節(jié)炎中醫(yī)診療專家共識(2015年版)[J].中醫(yī)正骨,2015,27(7):4-5.
[5] Kellgren JH,Lawrence JS.Radiological assessment of osteo-arthrosis[J].Ann Rheum Dis,1957,16(4):494-502.
[6] Bellamy N,Buchanan WW,Goldsmith CH,et al.Validation study of WOMAC:a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee[J].J Rheumatol,1988,15(12):1833-1840.
[7] Insall JN,Dorr LD,Scott RD,et al.Rationale of the knee society clinical rating system[J].Clin Orthop Relat Res,1989,(248):13-14.
[8] Losina E,Dervan EE,Daigle ME,et al.Studies of pain management in osteoarthritis: bedside to policy[J].Osteoarthritis Cartilage,2013,21(9):1264-1271.
[9] Stefanik JJ,Gross KD,Guermazi A,et al.The relation of MRI-detected structural damage in the medial and lateral patellofemoral joint to knee pain:the Multicenter and Framingham Osteoarthritis Studies [J].Osteoarthritis Cartilage,2015,23(4):565-570.
[10] Karsdal MA,Byrjalsen I,Alexandersen P,et al.Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin:results from two phase 3 trials[J].Osteoarthritis Cartilage,2015,23(4):532-543.
[11] Mandl LA,Losina E.Relative efficacy of knee osteoarthritis treatments:are all placebos created equal?[J].Ann Intern Med,2015,162(1):71-U116.

相似文獻/References:

[1]樊慶陽,任凱晶.定制3D打印切模輔助全膝關節(jié)置換術治療 膝骨關節(jié)炎合并股骨干骨折畸形愈合[J].中醫(yī)正骨,2015,27(11):37.
[2]劉曉雅,孫永強,劉國杰.主動快速康復鍛煉對全膝關節(jié)置換術后關節(jié)活動度的影響[J].中醫(yī)正骨,2015,27(09):73.
[3]鄭春松,葉蕻芝,李西海,等.透骨消痛膠囊中補腎柔肝藥和活血祛風藥治療 骨關節(jié)炎作用方式的計算機模擬比較[J].中醫(yī)正骨,2015,27(07):6.
 ZHENG Chunsong,YE Hongzhi,LI Xihai,et al.Comparison of the mode of action of Bushen Rougan(補腎柔肝)drugs versus Huoxue Qufeng(活血祛風)drugs contained in Tougu Xiaotong Jiaonang(透骨消痛膠囊)for the treatment of osteoarthritis:A computer simulation study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):6.
[4]宋兵華,孫俊英,倪增良,等.全膝關節(jié)置換術前CT測量股骨后髁角的臨床意義[J].中醫(yī)正骨,2015,27(07):38.
[5]鄭春松,葉蕻芝,李西海,等.獨活寄生湯含藥血清對白細胞介素1β誘導的 退變關節(jié)軟骨細胞中基質金屬蛋白酶 和環(huán)氧化酶2表達的影響[J].中醫(yī)正骨,2015,27(12):1.
 ZHENG Chunsong,YE Hongzhi,LI Xihai,et al.Impact of Duhuo Jisheng Tang(獨活寄生湯)medicated serum on expression of matrix metalloproteinase and cyclooxygenase 2 in degenerative articular chondrocytes induced by interleukin-1 beta[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):1.
[6]王金良,孫京濤,李玲,等.骨水泥聯(lián)合螺釘修復全膝關節(jié)置換術中 脛骨平臺內(nèi)側骨缺損[J].中醫(yī)正骨,2015,27(12):55.
[7]馮榮,王平,李炳奇,等.鈹針刺絡拔罐結合中藥口服治療膝骨關節(jié)炎合并 原發(fā)性血小板增多癥1例[J].中醫(yī)正骨,2015,27(12):73.
[8]蔡云仙.圍手術期耳穴按壓聯(lián)合平衡針療法 在全膝關節(jié)置換術后鎮(zhèn)痛中的應用[J].中醫(yī)正骨,2015,27(06):41.
[9]張榮,王健.人工全膝關節(jié)置換術的圍手術期心理護理[J].中醫(yī)正骨,2015,27(05):77.
[10]喻長純,楊明路,王戰(zhàn)朝.不同手術方式治療脛骨平臺骨折畸形愈合的體會[J].中醫(yī)正骨,2015,27(03):37.
[11]孟維娜,明立功,王新德,等.關節(jié)鏡下清理聯(lián)合腓骨近1/3段截骨治療膝骨關節(jié)炎[J].中醫(yī)正骨,2015,27(11):40.
[12]明立功,孟維娜,王新德,等.腓骨近端截骨治療內(nèi)側間室膝骨關節(jié)炎的近期療效觀察[J].中醫(yī)正骨,2015,27(10):25.
[13]張杰,王人彥,張玉柱.膝骨關節(jié)炎的治療進展[J].中醫(yī)正骨,2015,27(10):68.
[14]梁朝,蔡靜怡,閆立,等.針刀療法改善膝骨關節(jié)炎早期疼痛癥狀的療效評價[J].中醫(yī)正骨,2015,27(09):9.
 LIANG Zhao,CAI Jingyi,YAN Li,et al.Evaluation of the curative effect of needle-knife therapy for relieving knee pain in patients with early knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):9.
[15]王建武,黨建軍,李強,等.四聯(lián)療法治療膝骨關節(jié)炎[J].中醫(yī)正骨,2015,27(08):44.
[16]劉紅娟,郭會利,郭樹農(nóng).云克聯(lián)合中藥治療膝骨關節(jié)炎的護理[J].中醫(yī)正骨,2015,27(08):75.
[17]陳衛(wèi)衡.探索建立系統(tǒng)的膝骨關節(jié)炎中醫(yī)臨床科研范式 和理論體系[J].中醫(yī)正骨,2015,27(07):1.
[18]帥波,沈霖,楊艷萍,等.加味青娥丸治療膝骨關節(jié)炎的作用機制研究[J].中醫(yī)正骨,2015,27(07):15.
 SHUAI Bo,SHEN Lin,YANG Yanping,et al.Study on the mechanism of action of Jiawei Qing'e Wan(加味青娥丸)for the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):15.
[19]梅其杰,袁長深,段戡,等.壯藥骨痹方燙熨聯(lián)合運動療法治療膝骨關節(jié)炎的臨床研究[J].中醫(yī)正骨,2015,27(07):27.
 MEI Qijie,YUAN Changshen,DUAN Kan,et al.Clinical study of the curative effect of hot compressing and rubbing with packet of Gubi Fang(骨痹方)combined with exercise therapy in the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):27.
[20]王丹輝,張燕,劉麗娟,等.重組人Ⅱ型腫瘤壞死因子受體-抗體融合蛋白 關節(jié)腔注射聯(lián)合中藥薰洗治療膝骨關節(jié)炎的臨床研究[J].中醫(yī)正骨,2015,27(07):31.
 WANG Danhui,ZHANG Yan,LIU Lijuan,et al.Clinical study on intra-articular injection of TypeⅡrecombinant human tumor necrosis factor receptor-Fc fusion protein combined with Chinese herbal steaming and washing therapy for treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):31.

備注/Memo

備注/Memo:
基金項目:浙江省自然科學基金(LY16H060005); 中國博士后科學基金面上項目(2014M561793); 中國博士后科學基金特別資助項目(2015T80637); 國家自然科學基金青年項目(81302989); 浙江省中醫(yī)藥科技計劃項目(2013ZQ007)
通訊作者:童培建 E-mail:[email protected]
更新日期/Last Update: 2016-02-29